NCT04138940View on ClinicalTrials.gov

Modulating Intensity and Dosage of Aphasia Scripts

NACompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

September 21, 2020

Primary Completion Date

December 4, 2024

Study Completion Date

December 4, 2024

Conditions
Aphasia
Interventions
BEHAVIORAL

Script Training

Participant uses a computer program to practice scripts with a virtual therapist.

Trial Locations (1)

60611

Shirley Ryan Abilitylab, Chicago

All Listed Sponsors
collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

collaborator

Northwestern University

OTHER

collaborator

University of Colorado, Boulder

OTHER

lead

Shirley Ryan AbilityLab

OTHER

NCT04138940 - Modulating Intensity and Dosage of Aphasia Scripts | Biotech Hunter | Biotech Hunter